Metaxalone (Metaxalone) Patent Expiration, LOE Window & CMS Spending

Metaxalone (Metaxalone) by Primus: FDA Orange Book LOE 2043-05-14, 6 AB generics, $10.2M 2024 CMS Part D & Medicaid spend, and $3,750 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorPrimus
FDA Application & PathwayN022503 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2043-05-14
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors6
2024 CMS Total Public Spend$10.2M
2024 Medicare Part D Spend$8.5M
2024 Medicaid Spend$1.7M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($3,750 intro WAC)